Clinical Trials in Baltimore

Showing 21601-21620 of 23,476 trials

Effect of Ferrlecit® Versus Oral Iron on Iron Deficient Chronic Kidney Disease (CKD) Patients

NCT00224055

This study compares the effect of Ferrlecit® (a form of intravenous iron) to ferrous sulfate (a form of oral iron) in treating anemia and iron deficiency in chronic kidney disease patients who are not receiving erythropoietic agents (hormones that stimulate the bone marrow to make more red blood cells).

Anemia, Iron-DeficiencyKidney Failure, Chronic

Watson Pharmaceuticals89 participantsStarted Apr 2003

Tucson, Arizona, United States • Los Angeles, California, United States • Palo Alto, California, United States +21 more locations

TERMINATEDPhase 3< 1 mile

Comparative Study of Micafungin (FK463) Versus Placebo as Prophylactic Antifungal Therapy in the ICU

NCT00048750

The purpose of this study is to determine the efficacy and safety of intravenous micafungin versus placebo as prophylactic therapy for invasive fungal infections in patients in the intensive care unit considered to be at high risk.

Invasive Fungal Infections

Astellas Pharma Inc104 participantsStarted Jan 2003

Birmingham, Alabama, United States • Little Rock, Arkansas, United States • Los Angeles, California, United States +45 more locations

Effect of Ferrlecit® Versus Oral Iron on Iron Deficient Chronic Kidney Disease (CKD) Patients

Comparative Study of Micafungin (FK463) Versus Placebo as Prophylactic Antifungal Therapy in the ICU

Find Trials by Condition in Baltimore

Induction/Simplification With Atazanavir + Ritonavir + Abacavir/Lamivudine Fixed-Dose Combination In HIV-1 Infection

Effects of Single Oral Dose Dapagliflozin QT Study

A Study to Evaluate Platlet Aggregation of Clopidogrel, EC Aspirin 81 mg, EC Omeprazole 40 mg Compare to PA32540

PEG-Interferon Alfa-2b in Treating Young Patients With Plexiform Neurofibroma

Isolated Hepatic Perfusion With Melphalan in Treating Patients With Primary Unresectable Liver Cancer or Liver Metastases

Study of Decision Making in Patients Participating in Phase I Clinical Trials

Positron Emission Tomography Using [18F]-Labeled Substance P Antagonist Receptor Quantifier in Finding Disease in Patients With Pancreatic Cancer

Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas

CTS-1027 in Interferon-Naive Hepatitis C Patients

Study to Assess Efficacy of Tacrolimus + Methotrexate Versus Placebo + Methotrexate in Treatment of Rheumatoid Arthritis

Effects of Reiki, Yoga, Meditation, on the Physical and Psychological Symptoms of Chemotherapy-Induced Peripheral Neuropathy

Investigational Agent AG-013736 In Combinations With Standard Of Care Treatments For Patient's With Advanced Solid Tumor

Neoadjuvant Imatinib in Dermatofibrosarcoma Protuberans

Safety of Epicutaneous Immunotherapy for the Treatment of Peanut Allergy

Effect of Platelet Concentrate in Treatment of Diabetic Ulcers

Use of Cold and Compression Therapy With Total Knee Replacement Patients

Neoadjuvant Chemotherapy + Herceptin in HER2 Positive Stage II-III Breast Cancer Patients

Pressure Ulcer Prevention: Turning for Ulcer Reduction